|
|
_N_T_RP
|
|
||
Re: New interviewDr. Alkon at his very best with this concise and informative overview of the potential that Byrostatin has in treating Alzheimer's and other cognitive disorders. His level of confidence, tone, and vision for the future of Neurotrope speaks to a successful conclusion of the Confirmatory Phase 2 study, which results we await. |
return to message board, top of board |